These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 17982066)

  • 1. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of type 1 diabetes by gene therapy.
    Tian C; Bagley J; Cretin N; Seth N; Wucherpfennig KW; Iacomini J
    J Clin Invest; 2004 Oct; 114(7):969-78. PubMed ID: 15467836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
    Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA
    Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
    Wong FS; Du W; Thomas IJ; Wen L
    Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes resistance/susceptibility in T cells of nonobese diabetic mice conferred by MHC and MHC-linked genes.
    Ueno A; Cho S; Cheng L; Wang Z; Wang B; Yang Y
    J Immunol; 2005 Oct; 175(8):5240-7. PubMed ID: 16210629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.
    Mellanby RJ; Koonce CH; Monti A; Phillips JM; Cooke A; Bikoff EK
    J Immunol; 2006 Dec; 177(11):7588-98. PubMed ID: 17114428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
    Gerling IC; Serreze DV; Christianson SW; Leiter EH
    Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
    La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
    J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression.
    Serreze DV; Osborne MA; Chen YG; Chapman HD; Pearson T; Brehm MA; Greiner DL
    J Immunol; 2006 Nov; 177(10):6675-84. PubMed ID: 17082580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
    Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
    J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.
    Filippi CM; Estes EA; Oldham JE; von Herrath MG
    J Clin Invest; 2009 Jun; 119(6):1515-23. PubMed ID: 19478458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.
    Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B
    Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.